The federal government has committed $11 billion to expand the operating capacity of Federally Qualified Health Centers (FQHC), which receive federal funding and enhanced Medicaid and Medicare reimbursement, and "look-alike" ...
Jul 10, 2012
0
0
(Medical Xpress) -- With the U.S. Supreme Court decision looming on the fate of the Patient Protection and Affordable Care Act (PPACA) – informally known as Obamacare – two Texas Tech University researchers and ...
Jun 27, 2012
0
0
The ethical principles that have for centuries shaped the relationship between patient and physician should also guide legislators, regulators -- and justices of the highest court -- charged with crafting U.S. health care ...
Jun 20, 2012
0
0
Nine out of 10 Californians under the age of 65 will be enrolled in health insurance programs as a result of the Patient Protection and Affordable Care Act (ACA), according to a joint study by the UC Berkeley Center for Labor ...
Jun 14, 2012
0
0
More involvement by patients, clinicians and others in the health care community in developing comparative clinical effectiveness research studies will make such studies far more useful in clinical decision-making, according ...
Apr 17, 2012
0
0
The Texas Medical Board on Friday approved new rules on experimental stem cell therapies such as the one Gov. Rick Perry underwent during back surgery last year, despite objections they don't do enough to protect patients ...
Apr 13, 2012
0
0
Recent changes in health insurance status were linked to greater emergency department use by newly insured and newly uninsured adults, according to a study published Online First by Archives of Internal Medicine. The article ...
Mar 26, 2012
0
0
US President Barack Obama's landmark health reform faces a make-or-break test in the Supreme Court next week in a historic case likely to shape the nation's future political landscape.
Mar 23, 2012
0
0
(Medical Xpress) -- Even a $10 increase in premiums can drive people to a different health care plan. That's good news for health care reform, which relies heavily on competition and consumer response to pricing.
Mar 22, 2012
0
0
(AP) -- India effectively ended Bayer's monopoly on a patented cancer drug Monday, licensing a much cheaper generic under a unique law aimed at keeping costs affordable.
Mar 12, 2012
0
1
